Lantheus Holdings (LNTH) FCF Margin (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly FCF Margin came in at 32.31% in Q1 2026, up 502.0% year-on-year from 5.37% in Q1 2025, and up 121.22% on a QoQ basis from 14.6% in Q4 2025.
Lantheus Holdings (LNTH) FCF Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of FCF Margin data on file, last reported at 32.31% in Q1 2026.
- On a quarterly basis, FCF Margin rose 502.0% year-over-year to 32.31% in Q1 2026; TTM through Mar 2026 was 24.2%, a 970.0% decrease from a year earlier, with the FY2025 full-year figure at 22.97%, down 1222.0% from the prior year.
- FCF Margin for Q1 2026 stood at 32.31%, up from 14.6% in the prior quarter.
- Over the last five years, FCF Margin for LNTH reached as high as 1004.36% in Q4 2023 and fell as low as 13.58% in Q2 2023.
- Historically, FCF Margin has averaged 83.96% across 5 years, with a median of 30.51% in 2022.
- Across the five-year window, FCF Margin jumped 97130 bps in 2023 and sank 94464 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 33.06% in 2022, then jumped by 2938 bps to 1004.36% in 2023, then tumbled by 94 bps to 59.72% in 2024, then plunged by 76 bps to 14.6% in 2025, then surged by 121 bps to 32.31% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 32.31% in Q1 2026, 14.6% in Q4 2025, and 26.03% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 32.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.31% |
| Dec 31, 2025 | 14.60% |
| Sep 30, 2025 | 26.03% |
| Jun 30, 2025 | 24.59% |
| Mar 31, 2025 | 27.28% |
| Dec 31, 2024 | 59.72% |
| Sep 30, 2024 | 33.81% |
| Jun 30, 2024 | 14.63% |
| Mar 31, 2024 | 32.54% |
| Dec 31, 2023 | 1,004.36% |
| Sep 30, 2023 | 28.52% |
| Jun 30, 2023 | -13.58% |
| Mar 31, 2023 | 33.27% |
| Dec 31, 2022 | 33.06% |
| Sep 30, 2022 | 42.25% |
| Jun 30, 2022 | 30.51% |
| Mar 31, 2022 | 3.39% |
| Dec 31, 2021 | 1.35% |
| Sep 30, 2021 | 4.25% |
| Jun 30, 2021 | 25.60% |